This event was previously submitted on a summary report ((b)(4)). subsequently, medtronic has received additional information which is being submitted via this 3500a.This event has been reassessed and found to no longer qualify as a complaint for this device.No issue with the device occurred.Per the implant record, the label was supplied however, it was noted that the ¿bard avaulta anterior biosynthetic support system¿ was ¿opened but not implanted¿.It was placed in the table for reference but this product was not implanted.(b)(4).If information is provided in the future, a supplemental report will be issued.
|
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment.It was reported that after a procedure where this device was implanted, the patient experienced urinary tract infections, dyspareunia, bleeding or clotting disorders, constipation, cystocele, urinary incontinence, urinary retention, vaginal pain, cystoscopy, diabetic polyneuropathy, depression, herpes zoster, fistulae, bleeding, interstitial cystitis, and bleeding.She required both surgical and nonsurgical interventions.Concomitant devices used include avaulta solo synthetic support system - anterior; align s urethral support system suprapubic.
|